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The surface of an indwelling medical device can be colonized by human pathogens that can form
bioﬁlms and cause infections. In most cases, these bioﬁlms are resistant to antimicrobial therapy and
eventually necessitate removal or replacement of the device. An engineered surface
microtopography based on the skin of sharks, Sharklet AF™, has been designed on a polydimethyl
siloxane elastomer PDMSe to disrupt the formation of bacterial bioﬁlms without the use of
bactericidal agents. The Sharklet AF™ PDMSe was tested against smooth PDMSe for bioﬁlm
formation of Staphylococcus aureus over the course of 21 days. The smooth surface exhibited
early-stage bioﬁlm colonies at 7 days and mature bioﬁlms at 14 days, while the topographical
surface did not show evidence of early bioﬁlm colonization until day 21. At 14 days, the mean value
of percent area coverage of S. aureus on the smooth surface was 54% compared to 7% for the
Sharklet AF™ surface p0.01. These results suggest that surface modiﬁcation of indwelling
medical devices and exposed sterile surfaces with the Sharklet AF™ engineered topography may be
an effective solution in disrupting bioﬁlm formation of S. aureus. © 2007 American Vacuum
Society. DOI: 10.1116/1.2751405
I. INTRODUCTION
Bacterial bioﬁlms are a major concern in the development
of biomaterials, ultraﬁltration systems, and underwater ves-
sels. In the biomedical arena, bacterial colonization of sur-
faces compromises the effectiveness of implanted materials
and ultimately can result in persistent infections.1,2 Biomate-
rial surfaces for tissue constructs and implants are subject to
a competition between microbial adhesion and tissue integra-
tion, where an ideal surface would prevent the former while
promoting the latter.3 However, the chemical, mechanical,
and physical properties of tissue construct materials are in-
herently meant to enhance all forms of biogrowth, making it
equally likely that such a surface would submit to bacterial
colonization.
Microorganisms colonize biomedical implants by devel-
oping bioﬁlms, structured communities of microbial cells
embedded in an extracellular polymeric matrix that are ad-
herent to the implant and/or the host tissues.2,4 Bioﬁlms ren-
der microorganisms resistant to host defenses and antibiotic
therapy.5,6 The clinical means of managing bioﬁlms has been
prevention.
Preventing bioﬁlm-associated infections has traditionally
been through use of prophylactic antibacterial agents,
whether delivered systemically or released directly from the
biomaterial.7 Pharmacokinetics and toxicity of the antibacte-
rial agents incorporated in biomaterials have limited the ef-
fectiveness of such therapies.7–10 Antibiotics, antibodies, and
phagocytes can clear planktonic cells released by the bioﬁlm,
but the sessile communities themselves are resistant to such
agents.11,12 Antibiotic therapy resulting in incomplete eradi-
cation of bioﬁlm has been linked with the emergence of
antibiotic-resistant bacteria, which may compromise the ef-
fectiveness of these agents for even non-bioﬁlm-mediated
infections.13–16
Another strategy for preventing the development of bio-
ﬁlms has been to alter the biomaterial surface properties.
Surface modiﬁcation techniques to tailor the surface energy
via surface chemistry and surface topography have been de-
veloped to study the effects of changes in these surface prop-aElectronic mail: abrennan@mse.uﬂ.edu
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erties on bioﬁlm formation.17,18 Bacterial adhesion has been
investigated on surface topographies that range from random
structures to ordered arrays. There appears to be a trend to-
ward increased bacterial coverage as the Ra-roughness values
increased on electropolished steel.19 Conversely, P. aerugi-
nosa was less likely to foul hydrophilic, electrically neutral,
smooth polymeric surfaces.20 Interestingly, bacterial adhe-
sion was reduced on stainless steel surface microtopogra-
phies that were generated by a one-directional polishing ﬁn-
ish relative to smooth surfaces.21 The aforementioned studies
examined surfaces that were randomly roughened and did
not examine speciﬁc surface features. The effects of a non-
random topography consisting of etched grooves of varying
widths in silicon coupons with P. aeruginosa and P. ﬂuore-
scens showed that rates of attachment were independent of
groove size and greatest on the downstream edges of
grooves.22 More recently, microbial retention on a deﬁned
microtopography in the form of etched pits was determined
to be dependent on both the size of the surface defect and the
cell.23
The purpose of our study was to investigate the potential
for bacterial attachment and colonization on an engineered
topography with a well-deﬁned structure. Our research is fo-
cused on the design and characterization of surface microto-
pographies that effectively control bioadhesion, with the goal
to produce a biomaterial with topography variants that can
effectively switch from bioﬁlm forming to bioﬁlm inhibition.
To achieve this, a surface energy model was created corre-
lating wettability with bioadhesion to characterize and de-
velop settlement-enhancing as well as antifouling
topographies.24 The application of this model led to the de-
sign concept of a biomimetic structure inspired by the skin of
fast-moving sharks Sharklet AF™, and an engineered
roughness index ERI was developed as an extension of this
model to study and develop other unique engineered
topographies.25
In this article, a surface of uniform chemistry with an
engineered microtopography was investigated for the inhibi-
tion of bacterial bioﬁlm formation. The most successful de-
sign to date is Sharklet AF™. This particular microtopogra-
phy is unique from the aforementioned ones in that it has
nonrandom, clearly deﬁned surface features that are typically
tailored to the critical dimensions of the fouling organism.
Recent results on the Sharklet AF™ and other engineered
microtopographies designed at a 2 m feature width and
spacing have shown a strong correlation between the ERI
and the inhibition of settlement by the zoospores 5 m in
diameter of the most common ship fouling alga, Ulva.25 In
addition, the Sharklet AF™ microtopography designed at a
20 m feature width and spacing has been demonstrated to
be a strong inhibitor of the settlement of barnacle cyprids of
B. amphitrite.26 This organism’s attachment disk measures
25–30 m.27 For the present study, the Ulva-speciﬁc Shar-
klet AF™ surface was selected for the potential to inhibit
bioﬁlm formation of Staphylococcus aureus based on the ap-
proximate match between the size of the bacteria and the
critical dimensions of this surface 2 m feature width and
spacing, 3 m feature height. It was hypothesized that the
dimensions of the topography would be slightly too large to
effectively reduce the attachment of the bacteria in the size
range of 1–2 m but could be effective at physically dis-
rupting the further colonization of additional bacteria and
subsequent formation of bioﬁlm Fig. 1. S. aureus was se-
lected as the bacterial pathogen due to both its size and its
association with nosocomial infections in implanted devices,
such as cochlear implants, sutures, and heart valves.10,28
II. MATERIALS AND METHODS
A. Materials
Dow Corning® Silastic® T-2, a platinum-catalyzed poly-
dimethyl siloxane elastomer PDMSe, was used for its low
modulus, low surface energy, and propensity for minimal
bioadhesion.29 Silastic® brand silicone elastomers are bio-
materials used in numerous medical devices including tub-
ing, catheters, and pacemaker leads. The elastomer was pre-
pared by mixing one part by weight of curing agent with ten
parts by weight of resin, then degassing under vacuum
28–30 in. Hg for 30 min. The mixture was cured at
22 °C for 24 h.
FIG. 2. Locations A–C for scanning electron microscopy SEM analy-
sis for 8 mm circular PDMSe samples.
FIG. 1. Sharklet AF™ topography on polydimethyl si-
loxane elastomer PDMSe with 2 m feature width
and spacing and 3 m feature height. A Light micro-
graph with top-down view. B Scanning electron mi-
crograph with top down view. C Scanning electron
micrograph taken at 35° tilt to show protruding
features.
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B. Sharklet AF™ design and fabrication of
topographical molds
The Sharklet AF™ design24,25 consists of 2 m wide rect-
angular ribs of varying lengths ranging from 4 to 16 m.
The ribs of varying lengths are combined into a periodic,
diamondlike array at a ﬁxed spacing of 2 m between neigh-
boring features Fig. 1. The ﬁnal, resultant Sharklet AF™
topography in PDMSe was created by replication of silicon
wafer molds. Silicon wafer molds were fabricated by ﬁrst
transferring the Sharklet AF™ design to photoresist-coated
silicon wafers using photolithographic techniques as previ-
ously described.30 Next, the patterned silicon wafers were
deep reactive ion etched to a depth of 3 m before being
cleaned of residual photoresist with an O2 plasma etch. The
etched silicon wafer surfaces were then methylated via va-
por deposition with hexamethyldisilazane to prevent adhe-
sion. These wafers served as negative molds for topographi-
cal replication of the Sharklet AF™ topography at a feature
height of 3 m onto a PDMSe surface.
C. Sample preparation
Silicon molds were replicated into PDMSe to produce
0.4 mm thick ﬁlms containing protruding topographical
features. Brieﬂy, the PDMSe material components were pre-
pared and mixed as described,24,25 poured over the silicon
wafer molds, and the entire system was pressed between two
larger glass plates with the appropriate spacers to produce a
0.4 mm thick ﬁlm. After curing for 24 h, the PDMSe ﬁlm
was removed from the silicon wafer with protruding topo-
graphical features forming the Sharklet AF™ topography on
the PDMSe surface Fig. 1. PDMSe samples of smooth
replicated from an unmodiﬁed silicon wafer and topo-
graphically modiﬁed were punched out with a circular die
8 mm in diameter. Five replicates each of smooth PDMSe
and Sharklet AF™ PDMSe disks were placed into 3 in. Petri
dishes one dish for each day examined for the growth assay
and gas sterilization.
D. S. aureus bioﬁlm formation assay
Staphylococcus aureus ATCC 29213 was subcultured in
tryptic soy broth TSB growth medium and grown at 37 °C
overnight in static conditions. Optical absorbance was mea-
sured, serial dilutions were performed, and growth curve and
linear optical density-colony-forming unit CFU regression
were plotted. Bacterial concentration was determined via
spectrophotometry by interpolating CFU per milliliter from
the linear optical density-CFU regression. Samples were
statically immersed in a 107 CFU/ml bacterial suspension
for up to 21 days. Every day, dishes were put on a rocker for
1 min at 30 rpm and the medium was replaced to allow for
continued bacterial growth. Dishes were removed on days 0,
2, 7, 14, and 21. For each removed dish, areas surrounding
FIG. 3. A and B SEM images 2000  of S. au-
reus on smooth and topographically modiﬁed PDMSe
surfaces after 7 day exposure. C and D Processed
SEM images of smooth and Sharklet AF™ PDMSe sur-
faces using MACROMEDIA FIREWORKS®. Bacteria covered
areas were outlined and blackened.
FIG. 4. Grouping and numbering of bacteria colonies as
measured by IMAGEJ software. The analysis pictured
was conducted on the processed SEM images in Fig. 3.
A Bacteria coverage on a smooth PDMSe surface was
detected as two colonies. B Bacteria coverage on a
Sharklet AF™ PMDSe surface was detected as over 40
individual colonies of bacteria.
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the samples on the placement grid were rinsed with de-
ionized water using a Pipet-Aid® and aspirated to eliminate
nonadherent cells. This rinsing procedure was repeated for a
total of three times, and the dish was then put on an orbital
rocker for 1 min at 30 rpm. Each sample in the dish was then
treated with 20 ml of 10 mM cetyl-pyridinium chloride ﬁxa-
tive and allowed to air dry overnight. Another dish exposed
only to sterile medium was incubated with the samples for
21 days and served as a negative control.
E. Characterization
Samples were dehydrated in a graded ethanol series of
25%, 50%, 75%, 95%, and 100% at 10 min intervals.
Samples were washed twice with hexamethyldisilazane with
a 5 min interval between washings, followed by drying using
a vacuum desiccator. Each sample was attached to a beveled
disk and sputter coated with Au/Pd and imaged with a JEOL
6400 scanning electron microscope SEM. SEM images at
2000 from areas A, B, and C for each replicate were used
to quantify bacterial growth on each surface Fig. 2.
Bioﬁlms were identiﬁed by the presence of microorgan-
isms and exopolymeric matrix. Bioﬁlm growth was esti-
mated by measuring the percent area of coverage of bacteria.
To obtain this value, SEM images were ﬁrst processed using
MACROMEDIA FIREWORKS® software to outline and blacken
the area containing bacteria and/or bioﬁlm e.g., Fig. 3.
Processed SEM images were analyzed for percent cover-
age using IMAGEJ software.31 Areas of coverage were num-
bered and outlined, and the total summation of area covered
was measured e.g., Fig. 4. For each replicate, the results for
areas A, B, and C are combined to reﬂect the percentage
coverage of bacteria for that speciﬁc replicate. Results for
each replicate are reported as percent coverage of bacterial
colonies.
F. Statistical analysis
The mean value  standard error of percent area cover-
age of bacteria on both smooth and Sharklet AF™ PDMSe
surfaces at days 0, 2, 7, 14, and 21 was calculated. Statistical
differences were evaluated by a two-way analysis of variance
for the factors of “surface” smooth versus Sharklet AF™
and “day” 0, 2, 7, 14, and 21 followed by Tukey’s test for
multiple comparisons. Statistical differences were considered
at the 95% conﬁdence level.
III. RESULTS
On day 0, individual cells were seen on the surfaces of
smooth PDMSe Fig. 5A, while individual cells appeared
in the recesses between the protruding features for Sharklet
AF™ PDMSe surfaces Fig. 5B. On day 2, microcolonies
of bacteria began to form on the smooth surfaces Fig. 5C,
and the Sharklet AF™ surfaces continued to have isolated
cells accrete between features Fig. 5D. Growth of the
microcolonies increased on day 7 for the smooth surfaces
into early-stage bioﬁlms Fig. 5E. The Sharklet AF™ sur-
faces day 7 continued to exhibit small-sized clusters of bac-
teria, with no evidence of early-stage bioﬁlm development;
the clusters were positioned similar to day 2 in the recesses
between protruding topographical features Fig. 5F. On
day 14, the smooth surfaces had the ﬁrst evidence of mature
bioﬁlms Fig. 5G, while the Sharklet AF™ surfaces had a
slight increase in the number of small clusters of cells com-
pared to day 7 but still no evidence of early bioﬁlm devel-
opment or formation Fig. 5H. On day 21, a signiﬁcant
portion of the smooth PDMSe surfaces was colonized by
bioﬁlms Fig. 5I, and bioﬁlms ﬁrst appeared in isolated
areas on the Sharklet AF™ PDMSe surfaces Fig. 5J. Ar-
eas surrounding the large bacterial colonies on the topo-
graphical surfaces for day 21 were virtually devoid of adher-
ent bacteria. SEM images of the negative control samples
exposed to only TSB media showed no cells.
FIG. 5. Representative SEM images of S. aureus on PDMSe surfaces over
the course of 21 days areas of bacteria highlighted with color to enhance
contrast. On the left are smooth PDMSe surfaces and the right column
shows Sharklet AF™ PDMSe surfaces. A and B day 0, C and D day
2, E and F day 7, G and H day 14, and I and J day 21.
92 Chung et al.: Impact of engineered surface microtopography 92
Biointerphases, Vol. 2, No. 2, June 2007
Image and statistical analysis indicated that smooth
PDMSe samples had signiﬁcant increases in bacterial cover-
age for pooled time points Tukey’s test, p0.05, with the
ﬁrst evidence of bioﬁlm on day 7 samples. The Sharklet
AF™ samples had signiﬁcantly lower values of percent area
coverage for days 7, 14, and 21 Tukey’s test, p0.05, with
bioﬁlm colonies not appearing until day 21. Even on day 21,
bioﬁlm colonies covered only isolated areas on Sharklet
AF™ samples, with little to no evidence of bioﬁlms or bac-
terial cells in other areas. The mean value  standard error
of percent area coverage of bacteria on both smooth and
Sharklet AF™ PDMSe surfaces at days 0, 2, 7, 14, and 21
was calculated and is graphically displayed Fig. 6.
IV. DISCUSSION
Most in vitro studies involving S. aureus have examined
the adhesion behavior over the course of a few hours.16,19
However, for transcutaneous devices such as catheters, the
time frame for bioﬁlm formation is typically 14 days.7 Thus,
the focus of this study was to test the effects of an engineered
microtopography on bacterial colonization and bioﬁlm for-
mation for a period of time that extended beyond 14 days.
The growth assay parameters included optimized conditions
for S. aureus colonization and spanned 21 days. To date, this
is the ﬁrst in vitro study involving surface topography and S.
aureus over a time period approximating that of short-term
indwelling devices.
Material selection in this study was predicated upon the
popularity of silicone as the choice material for molded im-
plants, such as cochlear implants and long-term catheters,
despite being shown to have nearly a tenfold greater risk of
infection than other polymer materials.32 The static culture
provided for bioﬁlm growth was chosen to represent the
most challenging environment for the material surface in the
presence of bacteria, as opposed to the low shear dynamics
of indwelling catheters. The results of this study strongly
suggest that the surface modiﬁcation of existing silicone de-
vices with the Sharklet AF™ topography may prolong the
service life and improve the efﬁcacy of these devices. It is
also encouraging to note that the topographical modiﬁcation
of a surface used in this study involves no chemical changes
of the biomaterial surface and does not rely on the release of
any antibacterial agents.
Both qualitative e.g., development of extracellular ma-
trix and quantitative measures of bioﬁlm formation revealed
inhibition of bioﬁlm development on PDMSe with Sharklet
AF™ microtopography. The results conﬁrm the hypothesis
that cells can ﬁt in the recessed regions between the pro-
truded topographical features, but evidence of bioﬁlm forma-
tion did not occur on the Sharklet AF™ features until day 21.
The raised features could potentially reduce the surface area
exposed to bacteria if the channels failed to ﬁll with growth
media. However, ﬁnding bacteria strictly in the Sharklet
AF™ channels speaks against this possibility. Observations
of adhered bacteria would suggest that the protruded features
of the topographical surface provided a physical obstacle to
deter the expansion of small clusters of bacteria present in
the recesses into microcolonies. It was at day 21 when bac-
teria were observed to form small, multilayered colonies
within the recesses in order to extend over the protruding
features and connect to other isolated colonies. This phenom-
enon may be the explanation for the delay of early-stage
bioﬁlm development to day 21 that was evident on the
smooth surface at day 7.
In the context of the “race for the surface” in
biomaterials,3 our engineered surface approach suggests the
use of a hierarchy of surface topographies26 to control bio-
adhesion. Previous results detailing an engineered topogra-
phy capable of promoting cell growth33 can be integrated
into the Sharklet AF™ in this study to produce a hierarchical
topography for desirable competitive adhesion at the bioma-
terial surface. One can envision a surface that repels and
delays bioﬁlm formation to the extent that host cells, vital to
the integration of the biomaterial with the physiological en-
vironment, can be established and proliferated on the de-
signed surface.
This study was performed using a highly simpliﬁed in
vitro model. A great deal of work is needed to determine if
FIG. 6. Mean value of percent area coverage of bacteria
on smooth and Sharklet AF™ PDMSe surfaces at vari-
ous time points. Bars represent±standard error, n=5.
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observations from this in vitro model are borne out in vivo.
Current research is evaluating the adhesion and bioﬁlm for-
mation tendencies of other bioﬁlm-forming bacteria on Shar-
klet AF™. Also, the application of the engineered roughness
index is being used to predict other engineered topographies
that may be effective at inhibiting bioﬁlm formation. Consid-
erations for designing the optimal microtopography for an
implantable device will include the interactions with host
molecules and impact on ﬁbrous capsule formation.
V. CONCLUSIONS
S. aureus was cultured on PDMSe surfaces for up to
21 days. Bioﬁlms were established after 14 days on the
smooth PDMse surfaces whereas an engineered surface mi-
crotopography with nonrandom, clearly deﬁned features elic-
ited a negative response. The Sharklet AF™ microtopogra-
phy disrupted S. aureus colonization and bioﬁlm formation
without the use of bactericidal agents. Engineered surface
microtopographies present a promising means of blocking
bioﬁlm development and reducing the rate of biomedical im-
plant infections.
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